Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jip T. van Dinter
Observed names:
Jip T van Dinter,
Jip Van Dinter,
Jip van Dinter,
van Dinter, Jip T.
Institutions:
The Netherlands Cancer Institute,
Oncode Institute,
Princess Máxima Center
Observed institutions:
Utrecht University,
The Netherlands Cancer Institute,
University Medical Center Utrecht,
Oncode Institute,
Princess Máxima Center
ORCID:
0000-0002-3749-1531
Observed ORCID:
0000-0002-3749-1531
OpenAlex ID:
A5053018926
Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma
2024
·
Damon A. Hofman
, Jorge Ruiz-Orera
, et al.
·
Molecular Cell
·
93
PDF
H3K27ac acetylome signatures reveal the epigenomic reorganization in remodeled non-failing human hearts
2020
·
Jiayi Pei
, Magdalena Harakalova
, et al.
·
Clinical Epigenetics
·
41
PDF
Community benchmarking and evaluation of human unannotated microprotein detection by mass spectrometry based proteomics
2026
·
Aaron Wacholder
, Eric W. Deutsch
, et al.
·
Nature Communications
·
32
PDF
Translational readthrough of nonsense mutant TP53 by mRNA incorporation of 5-Fluorouridine
2022
·
Mireia Palomar-Siles
, Angelos Heldin
, et al.
·
Cell Death and Disease
·
32
PDF
The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2024
·
Michael V. Martin
, Salvador Aguilar-Rosas
, et al.
·
Cancer Immunology Research
·
16
PDF
Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1
2024
·
Annelisa M. Cornel
, Loutje van der Sman
, et al.
·
Journal for ImmunoTherapy of Cancer
·
5
PDF
Mutation accumulation in mtDNA of cancers resembles mutagenesis in normal stem cells
2022
·
Freek Manders
, Jip van Dinter
, et al.
·
iScience
·
5
Histone methyltransferase DOT1L differentially affects the development of dendritic cell subsets
2026
·
Rianne G. Bouma
, Willem-Jan de Leeuw
, et al.
·
Life Science Alliance
·
1
PDF
Mdb-32. Translation of Non-canonical Open Reading Frames as a Cancer Cell Survival Mechanism in Childhood Medulloblastoma
2023
·
Damon Hofman
, Jorge Ruiz-Orera
, et al.
·
Neuro-Oncology
·
1
PDF
A multi-omics analysis of advanced triple-negative breast cancer identifies predictors to chemo-immunotherapy and on-treatment dynamics
2026
·
Nicolaas Van Renne
, Elisa Agostinetto
, et al.
·
Cell Reports Medicine
Figure S13 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026
·
Michael V. Martin
, Salvador Aguilar-Rosas
, et al.
Figure S14 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026
·
Michael V. Martin
, Salvador Aguilar-Rosas
, et al.
Figure S16 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026
·
Michael V. Martin
, Salvador Aguilar-Rosas
, et al.
Figure S11 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026
·
Michael V. Martin
, Salvador Aguilar-Rosas
, et al.
Figure S12 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026
·
Michael V. Martin
, Salvador Aguilar-Rosas
, et al.
Figure S9 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026
·
Michael V. Martin
, Salvador Aguilar-Rosas
, et al.
Figure S4 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026
·
Michael V. Martin
, Salvador Aguilar-Rosas
, et al.
Figure S6 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026
·
Michael V. Martin
, Salvador Aguilar-Rosas
, et al.
Figure S2 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026
·
Michael V. Martin
, Salvador Aguilar-Rosas
, et al.
Figure S5 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026
·
Michael V. Martin
, Salvador Aguilar-Rosas
, et al.
Figure S1 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026
·
Michael V. Martin
, Salvador Aguilar-Rosas
, et al.
Figure S3 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026
·
Michael V. Martin
, Salvador Aguilar-Rosas
, et al.
Figure S15 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026
·
Michael V. Martin
, Salvador Aguilar-Rosas
, et al.
Figure S7 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026
·
Michael V. Martin
, Salvador Aguilar-Rosas
, et al.
Figure S10 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2026
·
Michael V. Martin
, Salvador Aguilar-Rosas
, et al.
Show more works
View as search
Works count:
79
Citation count:
226
H-index:
5
I10-index:
5
Year
Topic
Type